Bergstralh, Daniel T <br/><br/>
Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination.  [electronic resource] 

 -  Cancer treatment reviews  May 2006 
 - 166-79 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0305-7372 
<br/><br/><label>Standard No.: </label>10.1016/j.ctrv.2006.01.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkanes--pharmacology<br/>Animals<br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Carbamates--pharmacology<br/>Cyclooxygenase 2--metabolism<br/>Diterpenes--pharmacology<br/>Epothilones--pharmacology<br/>Humans<br/>Inhibitor of Apoptosis Proteins--metabolism<br/>Interleukin-1--metabolism<br/>Interleukin-8--metabolism<br/>Lactones--pharmacology<br/>MAP Kinase Kinase 1--metabolism<br/>MAP Kinase Signaling System--drug effects<br/>Macrolides<br/>Maturation-Promoting Factor--metabolism<br/>Microtubule-Associated Proteins--metabolism<br/>Microtubules--drug effects<br/>NF-kappa B--metabolism<br/>Neoplasm Proteins--metabolism<br/>Neoplasms--drug therapy<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Pyrones--pharmacology<br/>Signal Transduction--drug effects<br/>Survivin<br/>Taxoids--pharmacology<br/>Tumor Suppressor Protein p53--metabolism